Related Experiment Video
Updated: Sep 17, 2025
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
How Does Disease Severity Affect Clinical Outcomes and Economic Burden of Patients with COPD -- A Retrospective
Lei Wang1,2, Ke Huang3,4,5, Xiaoning He1,2
1School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, People's Republic of China.
Introduction:
Quantifying the disease burden across severity levels is essential for early intervention and effective management of chronic obstructive pulmonary disease (COPD). This study aimed to clarify the effect of severity on disease burden by comparing clinical and economic outcomes stratified by disease severity based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD) in a Chinese setting.
Methods:
A retrospective population-based cohort study was conducted using electronic health records of 80 hospitals (2016-2019). Patients (≥40 years) diagnosed with COPD (ICD-10: J44) between 2017 and 2018 were identified and further classified into high (GOLD E) or low (GOLD A/B) exacerbation risk groups based on 12-months pre-index exacerbation history. GOLD groups A, B, and E were categorized based on exacerbation history and prior symptom burden. Clinical and economic outcomes were examined during 12-months follow-up, including incidence and time intervals between exacerbations, mortality, healthcare resource utilization, and direct medical costs.
Results:
Among 6759 COPD patients (mean age 68.36 ± 11.46 years, 62.4% male), patients in group E (N=2378) showed significantly worse outcomes than group A/B (N=4381): 57% higher exacerbations risk (90.5 vs 70.5%, adjusted hazard ratio [HR]=1.57; 95% CI: 1.48-1.67), 31% higher risk of all-cause mortality (11.6 vs 6.6%, HR=1.31; 95% CI: 1.10-1.57), and 1.7-fold higher COPD-related total costs (Chinese yuan [CNY] 21,156 vs 12,457, adjusted difference CNY 4238) during follow-up. Notably, the incidence rates of overall exacerbation, total costs increased progressively from group A to B to E in the year following the index date.
Conclusion:
Poor prognosis and high economic burden were observed among Chinese patients with COPD. Higher disease severity was associated with increased risk of exacerbation, all-cause mortality, and economic burden. These findings underscore the need for early intervention in patients with mild COPD to prevent disease progression, subsequent exacerbations, and rising economic impacts.
More Related Videos
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: